In vitro Assessment of Ulva lactuca Mediated Selenium Nanoparticles (USeNPs) through Elevating the Action of Ketoconazole Antibiotic against Pathogenic Yeast Species and Wound Healing Capacity through Inhibition of Cyclooxygenase (Cox-1) Activity
Makhlof, M., El-Sheekh, M., Al-Tuwaijri, M., El-Tarabily, K., Elsayed, A. (2023). In vitro Assessment of Ulva lactuca Mediated Selenium Nanoparticles (USeNPs) through Elevating the Action of Ketoconazole Antibiotic against Pathogenic Yeast Species and Wound Healing Capacity through Inhibition of Cyclooxygenase (Cox-1) Activity. EKB Journal Management System, 63(3), 1155-1171. doi: 10.21608/ejbo.2023.220267.2393
Mofida E.M. Makhlof; Mostafa M. El-Sheekh; Majdah M. Al-Tuwaijri; Khaled A. El-Tarabily; Abeer Elsayed. "In vitro Assessment of Ulva lactuca Mediated Selenium Nanoparticles (USeNPs) through Elevating the Action of Ketoconazole Antibiotic against Pathogenic Yeast Species and Wound Healing Capacity through Inhibition of Cyclooxygenase (Cox-1) Activity". EKB Journal Management System, 63, 3, 2023, 1155-1171. doi: 10.21608/ejbo.2023.220267.2393
Makhlof, M., El-Sheekh, M., Al-Tuwaijri, M., El-Tarabily, K., Elsayed, A. (2023). 'In vitro Assessment of Ulva lactuca Mediated Selenium Nanoparticles (USeNPs) through Elevating the Action of Ketoconazole Antibiotic against Pathogenic Yeast Species and Wound Healing Capacity through Inhibition of Cyclooxygenase (Cox-1) Activity', EKB Journal Management System, 63(3), pp. 1155-1171. doi: 10.21608/ejbo.2023.220267.2393
Makhlof, M., El-Sheekh, M., Al-Tuwaijri, M., El-Tarabily, K., Elsayed, A. In vitro Assessment of Ulva lactuca Mediated Selenium Nanoparticles (USeNPs) through Elevating the Action of Ketoconazole Antibiotic against Pathogenic Yeast Species and Wound Healing Capacity through Inhibition of Cyclooxygenase (Cox-1) Activity. EKB Journal Management System, 2023; 63(3): 1155-1171. doi: 10.21608/ejbo.2023.220267.2393

In vitro Assessment of Ulva lactuca Mediated Selenium Nanoparticles (USeNPs) through Elevating the Action of Ketoconazole Antibiotic against Pathogenic Yeast Species and Wound Healing Capacity through Inhibition of Cyclooxygenase (Cox-1) Activity

Egyptian Journal of Botany
Article 30, Volume 63, Issue 3, September 2023, Page 1155-1171  XML PDF (4.86 MB)
Document Type: Regular issue (Original Article)
DOI: 10.21608/ejbo.2023.220267.2393
View on SCiNiTO View on SCiNiTO
Authors
Mofida E.M. Makhlof1; Mostafa M. El-Sheekh email 2; Majdah M. Al-Tuwaijri3; Khaled A. El-Tarabily4; Abeer Elsayed1
1Department of Botany and Microbiology, Faculty of Science, Damanhour University, Damanhour, 22516, Egypt
2Botany Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt
3Department of Biology, Faculty of Applied Science, Umm Al-Qura University, Makkah Al-Mukarramah, 21955, Saudi Arabia
4Department of Biology, College of Science, United Arab Emirates University, Al Ain, 15551, United Arab Emirates
Abstract
Ulva selenium nanoparticles (USeNPs) were synthesized and characterized, then examined for their wound healing capacity through in vitro assay showing promising healing (82.27%) with USeNPs concentration (500 µg/mL). We also determined the antifungal potential via agar well diffusion technique, minimum inhibitory concentration (MIC), which was evaluated by a micro-dilution assay.  The synergistic effect of the USeNPs individually or in combination with standard antifungal antibiotic (ketoconazole;100 μg/mL) was studied against Cryptococcus neoformans RCMB 0049001 and Candida lipolytica RCMB 005007(1). Geotrichum candidum RCMB 041001 was also checked by agar well diffusion assay, followed by transmission electron microscopy to assess different changes in the most sensitive fungal yeast cells. The results indicated that USeNPs have a promising antifungal effect against C. neoformans RCMB 0049001 and C. lipolytica RCMB 005007(1) by achieving remarkable inhibition zones. In comparison, no effect was detected on G. candidum RCMB 041001. The MIC was found to be 8.1 μg and 312.5 μg for C. neoformans RCMB 0049001 and C. lipolytica RCMB 005007(1), respectively. The biosynthetic USeNPs have a strong antifungal potential and can elevate and strengthen the action of ketoconazole antibiotic towards different fungal pathogens, and this was obvious in the synergetic experiment carried out in the present study based on combining ketoconazole;100 μg/mL with USeNPs, which resulted in a detached C. neoformas RCMB 0049001 cells with a severe dramatic change.
Keywords
Candida lipolytica; Cryptococcus neoformas; Cyclooxygenase (COX-1); Ketoconazole; Wound healing; Ulva lactuca; Ulva selenium nanoparticles
Statistics
Article View: 331
PDF Download: 468